Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.73 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.57 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.54 |
| ▸ | SLC40A1 | Q9NP59 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | PDE4A | P27815 | 2/20 | 0.47 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.47 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.47 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.47 |
| ▸ | KDM4A | O75164 | 2/20 | 0.46 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.46 |
| ▸ | KDM6B | O15054 | 1/20 | 0.46 |
| ▸ | KDM6A | O15550 | 1/20 | 0.46 |
| ▸ | TET3 | O43151 | 1/20 | 0.46 |
| ▸ | KDM4B | O94953 | 1/20 | 0.46 |
| ▸ | KDM5C | P41229 | 1/20 | 0.46 |
| ▸ | KDM4D | Q6B0I6 | 1/20 | 0.46 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21878477 | 0.88 | KDM4E (0.64) | KDM4EPSMD14MAP2K1SLC40A1PDE4A | |
| SCHEMBL19642874 | 0.88 | PSMD14 (0.69) | KDM4EPSMD14MAP2K1SLC40A1MEN1 | |
| SCHEMBL23714061 | 0.85 | KDM4E (0.56) | KDM4EMEN1KMT2ASMN1; SMN2KDM4A | |
| SCHEMBL6068105 | 0.84 | KDM4E (1.00) | KDM4EPSMD14MAP2K1KDM4AKDM4C | |
| SCHEMBL30744938 | 0.84 | KDM4E (1.00) | KDM4EPSMD14MAP2K1KDM4AKDM4C | |
| SCHEMBL9944372 | 0.84 | KDM4E (0.52) | KDM4EPSMD14MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL15758767 | 0.83 | KDM4E (0.71) | KDM4EPSMD14MAP2K1SLC40A1MEN1 | |
| SCHEMBL3503003 | 0.83 | KDM4E (0.71) | KDM4EPSMD14MAP2K1SLC40A1SMN1; SMN2 | |
| SCHEMBL20952065 | 0.83 | KDM4E (0.77) | KDM4EPSMD14MAP2K1SLC40A1MEN1 | |
| SCHEMBL17113034 | 0.83 | KDM4E (0.71) | KDM4EPSMD14MAP2K1SLC40A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8846291-B2 | Resist composition, method of forming resist pattern, and new compound | TOKYO OHKA KOGYO CO. LTD. (JP) | 2014-09-30 | — | — | US | disclosed |
| US-20120148955-A1 | RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, AND NEW COMPOUND | TOKYO OHKA KOGYO CO., LTD. (JP) | 2012-06-14 | — | — | US | disclosed |
| US-7098215-B2 | Nitrogenous compounds and antiviral drugs containing the same | KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) | 2006-08-29 | — | — | US | disclosed |
| US-20040092556-A1 | Nitrogenous compounds and antiviral drugs containing the same | KUREHA CORPORATION (JP) | 2004-05-13 | — | — | US | disclosed |
| EP-1273571-A1 | NITROGENOUS COMPOUNDS AND ANTIVIRAL DRUGS CONTAINING THE SAME | Kureha Chemical Industry Co., Ltd. (JP) | 2003-01-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040092556-A1 | Nitrogenous compounds and antiviral drugs containing the same | NSUN2, ZC3HAV1L, PNP | KDM4E 3110/4885PSMD14 1882/4885MAP2K1 3244/4885 |
| US-20120148955-A1 | RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, AND NEW COMPOUND | C1R, SLC11A2, RER1 | KDM4E 4730/4885PSMD14 4089/4885MAP2K1 2941/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.